Anguilla vs Maldives: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Anguilla
0.2%
in 2024
Maldives
0.2%
in 2024
Anguilla rank
78th
Maldives rank
78th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Anguilla
- Maldives
How they compare
Anguilla currently reports 0.2% against 0.2% in Maldives, a difference of 0.0%.
Across all 10 years both countries report, Maldives has been ahead every year.
Anguilla ranks 78th and Maldives ranks 78th of 215 countries.
Maldives has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Anguilla | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.4% | 0.1% | Maldives |
| 2020s | 0.2% | 0.2% | 0.0% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Anguilla or Maldives?
- Anguilla, at 0.2% against 0.2% in Maldives as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Anguilla and Maldives?
- 0.0%, with Anguilla ahead.
- How many years of comparable data are there for Anguilla and Maldives?
- 10 years are reported by both, from 2015 to 2024.
- How do Anguilla and Maldives rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Anguilla ranks 78th and Maldives ranks 78th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.